SCHEMBL6315604

SCHEMBL6315604

C1=COc2ccccc2-c2ccccc2OC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 4/20 0.37
CRHBP P24387 2/20 0.37
CRHR2 Q13324 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HTT P42858 1/20 0.37
ABCG2 Q9UNQ0 1/20 0.36
ITGB2 P05107 1/20 0.36
ICAM1 P05362 1/20 0.36
ITGAL P20701 1/20 0.36
CYP2B6 P20813 1/20 0.34
CYP19A1 P11511 3/20 0.33
KMT2A Q03164 2/20 0.33
MAOB P27338 2/20 0.32
KDM4E B2RXH2 3/20 0.32
TDP1 Q9NUW8 1/20 0.32
MAPK1 P28482 1/20 0.31
ATM Q13315 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6315597 1.00 PKM (0.41) PKMTSHRLMNACRHBPCRHR2
SCHEMBL2263211 0.85 SMN1; SMN2 (0.46) PKMTSHRLMNACRHBPCRHR2
SCHEMBL25135417 0.84 PKM (0.48) PKMTSHRLMNACRHBPCRHR2
SCHEMBL28332195 0.83 SMN1; SMN2 (0.44) PKMTSHRLMNACRHBPCRHR2
SCHEMBL10463800 0.73 PKM (0.39) PKMTSHRLMNACRHBPCRHR2
SCHEMBL7509071 0.71 ABCG2 (0.58) PKMTSHRLMNACRHBPCRHR2
SCHEMBL7509076 0.71 ABCG2 (0.58) PKMTSHRLMNACRHBPCRHR2
SCHEMBL22118168 0.70 LMNA (0.33) LMNACRHBPCRHR2SMN1; SMN2HTT
SCHEMBL7485477 0.69 PKM (0.48) PKMTSHRCYP2B6CYP19A1MAOB
SCHEMBL7485483 0.69 MAOB (0.41) PKMTSHRLMNACYP19A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288257-A1 Novel stable compositions of water and oxygen sensitive compounds and their method of preparation NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288257-A1 Novel stable compositions of water and oxygen sensitive compounds and their method of preparation COXFA4L2, CYP2F1, ABCG2 PKM 1079/4885TSHR 4327/4885LMNA 2909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.